Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Patients-Cd4'

Patients-Cd4 published presentations and documents on DocSlides.

Correctly modeling CD4 cell count in Cox regression analysis of HIV-positive patients
Correctly modeling CD4 cell count in Cox regression analysis of HIV-positive patients
by gagnon
Allison Dunning, M.S.. Research Biostatistician. W...
A point of care diagnostic device for monitoring CD4 levels in HIV patients in a resource poor sett
A point of care diagnostic device for monitoring CD4 levels in HIV patients in a resource poor sett
by sadie
Group 14:. Lina. . Aboulmouna. Peter . DelNero. P...
Correctly modeling CD4 cell count in Cox regression analysi
Correctly modeling CD4 cell count in Cox regression analysi
by myesha-ticknor
Allison Dunning, M.S.. Research Biostatistician. ...
1 Risk of progression to AIDS or death in relation to CD4 c
1 Risk of progression to AIDS or death in relation to CD4 c
by celsa-spraggs
Heiner C. Bucher for the Opportunistic Infections...
Association of Maternal Viral Load and CD4 Count with Perinatal HIV-1 Transmission Risk during Brea
Association of Maternal Viral Load and CD4 Count with Perinatal HIV-1 Transmission Risk during Brea
by easton
Patricia M. Flynn, MD, Taha E Taha, MD, Mae Cababa...
Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of ant
Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of ant
by daisy
Jean-Michel Molina, . Birgit. . Grund. , Fred . G...
INR IR Anti-CD4 IgG levels
INR IR Anti-CD4 IgG levels
by hadley
Plasma sCD4 . levels. NK . protein. . release. NK...
NKT CD4
NKT CD4
by min-jolicoeur
% of max. DCFDA. 12wk. 3wk. CD44-high. gated. Fig...
New drugs for individuals
New drugs for individuals
by Ziggystardust
with multi-resistant virus. 6 APRIL 2020. Faculty....
OPPORTUNISTIC INFECTIONS
OPPORTUNISTIC INFECTIONS
by genderadidas
In patients with untreated HIV infection, decreasi...
Challenges of treating two infections (HIV and TB):
Challenges of treating two infections (HIV and TB):
by karlyn-bohler
the ART of HIV/TB management. William Burman MD. ...
Charles B. Hicks, MD Professor of Medicine
Charles B. Hicks, MD Professor of Medicine
by karlyn-bohler
Duke University Medical Center. Durham, North Car...
High Rates of Tuberculosis in Patients Accessing HAART in R
High Rates of Tuberculosis in Patients Accessing HAART in R
by luanne-stotts
Kogieleum. . Naidoo . on behalf of. . Quarraish...
Figure S1. General gating and sorting strategies for
Figure S1. General gating and sorting strategies for
by dora
ex vivo. samples and lymph node biopsies. a). Tmr...
Article published online 20210809
Article published online 20210809
by danya
1 Avicenna Journal of Medicine / Jan-Mar 2014 / Vo...
Challenges in implementing
Challenges in implementing
by SpunkyFunkyGirl
LF-LAM in outpatient settings:. Experiences from M...
Abstract Background: Sporadic outbreaks of viral hepatitis and recent hepatitis A virus (HAV) outb
Abstract Background: Sporadic outbreaks of viral hepatitis and recent hepatitis A virus (HAV) outb
by jacey
Methods: . We analyzed the data of patients who pa...
Advanced HIV Disease Update: South
Advanced HIV Disease Update: South
by abigail
Africa. Letta Seshoka & Mokgadi Phokojoe. Nati...
HIV and other retroviral diseases (related oral infections) in Afro-Asian countries
HIV and other retroviral diseases (related oral infections) in Afro-Asian countries
by roxanne
Dr. Cathy Nisha John. University of the Western C...
CUTANEOUS MANIFESTATIONS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
CUTANEOUS MANIFESTATIONS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
by kylie
BY. DR. JAHNABI. MODERATOR. DR. BHASKAR GUPTA, PR...
Human Immunodeficiency Virus Part II
Human Immunodeficiency Virus Part II
by iris
Catherine . Czesnowski. MD.. PYG 1 IM. Pathogenes...
Nivolumab and
Nivolumab and
by carla
ipilimumab/-UV1 vaccination as 2ndline treatment i...
Dolutegravir monotherapy
Dolutegravir monotherapy
by alexa-scheidler
Dolutegravir monotherapy vs. dolutegravir/ abac...
Michael S. Saag , MD Eric S.
Michael S. Saag , MD Eric S.
by pamella-moone
Daar. , MD. Antiretroviral Therapy:. A Case-Based...
Hepatitis B Case Studies
Hepatitis B Case Studies
by alida-meadow
Nina Kim, MD MSc. Associate Professor of Medicine...
HUMAN IMMUNODEFICIENCY VIRUS DISEASE
HUMAN IMMUNODEFICIENCY VIRUS DISEASE
by marina-yarberry
BY: Dr. . Sha`bani. . AIDS first recognized in t...
Should we treat
Should we treat
by trish-goza
HIV Controllers ?. IAS 2013. Pr Olivier Lambotte....
Hepatitis B Case Studies
Hepatitis B Case Studies
by yoshiko-marsland
Nina Kim, MD MSc. Associate Professor of Medicine...
Paul Allyn, MD
Paul Allyn, MD
by conchita-marotz
African American HIV University. University of Ca...
Immunoprotection in HIV and Sexually Transmitted Infections
Immunoprotection in HIV and Sexually Transmitted Infections
by joy
Steven C. Johnson, M.D.. Professor of Medicine. Un...
Top 10 Things Missed in HIV
Top 10 Things Missed in HIV
by mackenzie
Primary Care. David H. Spach, MD. Editor-in-Chief....
SSC-A FSC-A FSC Width FSC Height
SSC-A FSC-A FSC Width FSC Height
by udeline
SSC-A. HLA-DR. Singlet cells. CD40-CD163-. CD40. C...
Novel Antiretroviral Studies and Strategies
Novel Antiretroviral Studies and Strategies
by danya
Bob Harrington, MD. University of Washington . Pre...
A nti- R etroviral T herapy Basics
A nti- R etroviral T herapy Basics
by caroline
E Duke. https://www.hiv.uw.edu/page/treatment/drug...
ART Scale-up Where to go in the next decade?
ART Scale-up Where to go in the next decade?
by cadie
Prof Charles Gilks. Head of School of Public Healt...
Effects of first -line antiretroviral
Effects of first -line antiretroviral
by esther
therapy. . on. . the. CD4/CD8 ratio and CD8 . ce...
Immunological diseases Dr.
Immunological diseases Dr.
by lucinda
Husham. . Aldaoseri. 11-Oct. 2023. Innate immunit...
Supplementary figures CD25+ PE
Supplementary figures CD25+ PE
by winnie
Foxp3+ PerCP-Cy5.5. Control. Model. Electro-Acupu...
HIV-AIDS Prof. OP rajoura
HIV-AIDS Prof. OP rajoura
by osullivan
HIV . v/s . AIDS. HIV: Human . Immuno. -deficienc...
IAS – USA Fall New York Course: Case Discussion
IAS – USA Fall New York Course: Case Discussion
by jalin
Luke . Jerram. Disclosures: Educational grant supp...